ImmunoPrecise Antibodies Ratios and Metrics

Market cap in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 14, 2025	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	2016 - 2020
Market Capitalization	91	20	34	64	131	187	Upgrade
Market Cap Growth	-40.49%	-40.49%	-47.50%	-50.98%	-30.05%	386.87%	Upgrade
Enterprise Value	94	20	40	61	107	178	Upgrade
Last Close Price	1.99	0.44	1.28	2.57	5.56	9.76	Upgrade
PS Ratio	3.74	1.13	1.89	4.21	8.66	12.87	Upgrade
PB Ratio	5.37	1.17	1.30	1.51	2.23	4.05	Upgrade
P/TBV Ratio	8.86	1.93	10.44	11.26	7.20	5.35	Upgrade
EV/Sales Ratio	5.29	1.13	2.23	4.02	7.09	12.22	Upgrade
Debt / Equity Ratio	0.57	0.57	0.38	0.13	0.04	0.06	Upgrade
Asset Turnover	0.47	0.47	0.36	0.24	0.24	0.38	Upgrade
Inventory Turnover	5.18	5.18	5.94	4.95	5.95	6.43	Upgrade
Quick Ratio	1.72	1.72	0.98	2.14	3.59	7.56	Upgrade
Current Ratio	2.08	2.08	1.41	2.84	4.03	8.05	Upgrade
Return on Equity (ROE)	-101.96%	-101.96%	-55.87%	-39.91%	-25.28%	-20.39%	Upgrade
Return on Assets (ROA)	-14.81%	-14.81%	-12.78%	-18.33%	-13.04%	-8.83%	Upgrade
Return on Capital (ROIC)	-17.91%	-17.91%	-15.39%	-21.96%	-15.12%	-10.40%	Upgrade
Earnings Yield	-23.82%	-109.15%	-56.41%	-30.53%	-9.96%	-3.19%	Upgrade
FCF Yield	-5.71%	-26.03%	-9.89%	-24.51%	-6.55%	-0.88%	Upgrade
Buyback Yield / Dilution	-30.23%	-30.23%	-2.97%	-26.46%	-19.51%	-20.88%	Upgrade

Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q